DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,349,664 | +3.4% | 5,440 | 0.0% | 0.40% | +7.8% |
| Q2 2023 | $1,305,600 | -4.8% | 5,440 | 0.0% | 0.37% | -6.1% |
| Q1 2023 | $1,371,098 | -5.0% | 5,440 | 0.0% | 0.40% | -6.4% |
| Q4 2022 | $1,443,885 | +2.5% | 5,440 | -0.2% | 0.42% | -1.4% |
| Q3 2022 | $1,408,000 | +1.9% | 5,450 | 0.0% | 0.43% | +14.1% |
| Q2 2022 | $1,382,000 | -13.6% | 5,450 | 0.0% | 0.38% | +3.9% |
| Q1 2022 | $1,599,000 | -10.8% | 5,450 | 0.0% | 0.36% | -3.5% |
| Q4 2021 | $1,793,000 | +7.6% | 5,450 | -0.5% | 0.37% | +1.9% |
| Q3 2021 | $1,667,000 | +13.5% | 5,475 | 0.0% | 0.37% | +9.2% |
| Q2 2021 | $1,469,000 | +19.2% | 5,475 | 0.0% | 0.34% | +10.2% |
| Q1 2021 | $1,232,000 | -10.2% | 5,475 | -11.3% | 0.30% | -22.4% |
| Q4 2020 | $1,372,000 | -9.3% | 6,175 | -12.1% | 0.39% | -22.5% |
| Q3 2020 | $1,513,000 | +13.7% | 7,025 | -6.6% | 0.51% | +1.6% |
| Q2 2020 | $1,331,000 | +21.3% | 7,525 | -5.0% | 0.50% | -6.7% |
| Q1 2020 | $1,097,000 | -9.8% | 7,925 | 0.0% | 0.54% | +19.4% |
| Q4 2019 | $1,216,000 | -0.1% | 7,925 | -5.9% | 0.45% | -5.5% |
| Q3 2019 | $1,217,000 | -21.7% | 8,425 | -22.5% | 0.47% | -23.8% |
| Q2 2019 | $1,554,000 | +8.2% | 10,875 | 0.0% | 0.62% | +4.0% |
| Q1 2019 | $1,436,000 | +12.5% | 10,875 | -12.1% | 0.60% | -8.8% |
| Q4 2018 | $1,276,000 | -7.3% | 12,375 | -2.4% | 0.66% | +12.3% |
| Q3 2018 | $1,377,000 | +10.1% | 12,675 | 0.0% | 0.58% | +11.5% |
| Q2 2018 | $1,251,000 | 0.0% | 12,675 | -0.8% | 0.52% | -7.3% |
| Q1 2018 | $1,251,000 | -3.9% | 12,775 | -8.9% | 0.56% | +2.9% |
| Q4 2017 | $1,302,000 | +3.7% | 14,025 | -4.1% | 0.55% | +1.7% |
| Q3 2017 | $1,255,000 | -5.4% | 14,625 | -7.0% | 0.54% | +0.4% |
| Q2 2017 | $1,327,000 | -1.3% | 15,725 | 0.0% | 0.54% | -2.9% |
| Q1 2017 | $1,345,000 | +7.9% | 15,725 | -1.8% | 0.55% | +0.5% |
| Q4 2016 | $1,247,000 | -0.7% | 16,017 | 0.0% | 0.55% | -3.5% |
| Q3 2016 | $1,256,000 | -20.9% | 16,017 | +1.9% | 0.57% | -22.2% |
| Q2 2016 | $1,588,000 | +0.7% | 15,725 | -5.4% | 0.73% | +4.3% |
| Q1 2016 | $1,577,000 | +2.1% | 16,625 | 0.0% | 0.70% | -5.0% |
| Q4 2015 | $1,544,000 | +9.0% | 16,625 | 0.0% | 0.74% | +2.6% |
| Q3 2015 | $1,417,000 | -3.3% | 16,625 | -2.9% | 0.72% | +5.7% |
| Q2 2015 | $1,466,000 | +0.3% | 17,125 | -0.6% | 0.68% | +1.3% |
| Q1 2015 | $1,462,000 | -0.9% | 17,225 | 0.0% | 0.67% | -1.0% |
| Q4 2014 | $1,476,000 | +9.0% | 17,225 | -3.4% | 0.68% | +3.5% |
| Q3 2014 | $1,354,000 | -8.1% | 17,825 | -4.8% | 0.66% | -7.3% |
| Q2 2014 | $1,474,000 | +3.1% | 18,725 | -1.7% | 0.71% | -1.7% |
| Q1 2014 | $1,429,000 | -5.8% | 19,050 | -3.1% | 0.72% | -7.3% |
| Q4 2013 | $1,517,000 | +8.6% | 19,650 | -2.5% | 0.78% | +0.8% |
| Q3 2013 | $1,397,000 | +9.2% | 20,150 | -0.2% | 0.77% | +3.9% |
| Q2 2013 | $1,279,000 | – | 20,200 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |